DPP4 and Miyoshi myopathy: huCD26mAb had little or no direct effect on CD26− MM cell lines cultured alone, but it directly and dose-dependently inhibited the growth of CD26+ MM cells co-cultured with OCs primarily at higher concentrations >10 μg/ml (Fig. 3a).